• Systematic Review
  • Diagnosis & Assessment
Clinical RelevanceDOI 4 min read
Jump to:

Patient-friendly summary

If you read nothing else

This review shows big differences in how doctors diagnose painful trigger points in muscles, suggesting a need for clearer guidelines.

Bottom line

High variability in diagnosing myofascial trigger points suggests a need for clearer standards.

Preliminary evidence

Not everyone agrees

This review highlights a lack of consensus and high variability in diagnosing myofascial trigger points, contrasting with the need for standardized criteria in clinical practice.

Published

2020
6 years ago
Recent

Evidence hierarchy

Meta-analysis
Systematic Review ◀ this study
RCT
Cohort
Case-Control
Case Report
Expert Opinion

Study participants

n=198unspecifiedunspecified

patients with musculoskeletal conditions characterized by at least 1 active MTrP or latent MTrP in any body area

Full research — for clinicians and curious readers

Study Summary

Background

Myofascial trigger points (MTrPs) are defined as hyperirritable painful spots in taut bands of skeletal muscles that contribute to musculoskeletal pain syndromes. Despite their clinical importance, there is no gold standard for diagnosing MTrPs, and significant variability exists in the diagnostic criteria used by researchers and clinicians. The lack of consensus on diagnostic criteria makes it difficult to compare research findings, replicate studies, and provide consistent clinical care. This systematic review aimed to update the understanding of how MTrPs are diagnosed in physical therapy clinical trials published between 2007 and 2019.

What They Did

The researchers searched MEDLINE and PEDro databases using systematic methodology to identify clinical trials of physical therapy interventions for patients with MTrPs. They analyzed 198 studies that met their inclusion criteria, examining what diagnostic criteria were reported and how they were combined to identify MTrPs. The research team extracted data on individual diagnostic criteria such as spot tenderness, referred pain, local twitch response, pain recognition, limited range of motion, and jump sign. They also assessed the methodologic quality of included studies using the PEDro scale and categorized studies by treatment type, body region affected, and whether they distinguished between active and latent MTrPs.

What They Found

Of the 198 studies included, only 129 (65.1%) clearly stated the diagnostic criteria used for MTrPs, while 56 studies (28.3%) failed to report any diagnostic method and 13 studies (6.6%) used vague expert-based definitions. The three most commonly used individual criteria were spot tenderness (96.9%), referred pain (73.6%), and local twitch response (48.8%). The researchers identified 23 different combinations of diagnostic criteria, with the most frequent being the combination of spot tenderness, referred pain, and local twitch response (used in 28 studies, 22%). Only 9 studies (4.5%) made a clear distinction between active and latent MTrPs, despite this being an important clinical distinction.

Most studies (70%) focused on MTrPs in the cervicothoracic region.

What This Means

This review reveals concerning inconsistency in how MTrPs are diagnosed in research studies, which undermines the ability to compare findings across studies and develop evidence-based treatments. The finding that over one-third of studies failed to clearly report diagnostic criteria represents a significant transparency problem in the literature. For clinicians, this suggests the need for standardized diagnostic approaches, with spot tenderness, referred pain, and local twitch response emerging as the most commonly accepted criteria. The lack of distinction between active and latent MTrPs in most studies is problematic since these may require different treatment approaches.

Future research should adopt clearer reporting standards and work toward developing validated diagnostic criteria for MTrPs.

85/100
Evidence StrengthStrong
Study Quality
Sample Size
Replication
Studies Reporting Clear Criteria
65.1%
Used Spot Tenderness
96.9%
Different Criteria Combinations
23

Results Comparison

Frequency of Diagnostic Criteria Usage

%
Spot Tenderness96.9 %
Referred Pain73.6 %
Local Twitch Response48.8 %
Pain Recognition45.7 %

Key Findings

FindingDetailImpact
Only 65.1% of studies clearly reported diagnostic criteria129 out of 198 studies stated specific diagnostic criteria, while 56 studies failed to report any diagnostic methodHigh
Spot tenderness was the most universal criterionUsed in 96.9% of studies that reported criteria, representing tender spots in taut bandsHigh
23 different combinations of criteria were identifiedMost common combination was spot tenderness + referred pain + local twitch response (22% of studies)High
Poor distinction between active and latent trigger pointsOnly 4.5% of studies clearly distinguished between active and latent MTrPs despite clinical importanceMedium
High variability in reporting quality28.3% of studies failed to report any diagnostic method, indicating transparency issuesHigh
Study Methodology
Study Design
Systematic review of clinical trials
Sample Size
198
Duration
Studies published 2007-2019
Population
Physical therapy clinical trials involving MTrP patients
Outcome Measures
Diagnostic criteria reporting · PEDro quality assessment · Criteria combinations

Strengths

  • Comprehensive search of major databases
  • Large sample of 198 clinical trials
  • Systematic methodology following PRISMA guidelines
  • Detailed analysis of diagnostic criteria combinations

Limitations

  • Limited to English-language publications
  • Focused only on physical therapy interventions
  • Did not assess validity of diagnostic criteria
  • Excluded invasive and pharmacological treatment studies

Key Takeaways for Patients

What This Means for You

  1. Trigger point diagnosis methods vary significantly between healthcare providers and research studies

  2. The most reliable signs of trigger points are tender spots in tight muscle bands, referred pain patterns, and muscle twitches

  3. Many studies don't clearly explain how they identify trigger points, which affects treatment recommendations

  4. Better standardization of diagnosis methods could improve consistency in trigger point treatment

  5. If you're seeking trigger point treatment, ask your provider which specific criteria they use for diagnosis

Read the Full Paper

Access the complete peer-reviewed study from Clinical Journal of Pain

View Full Study

Related Research

●●●●● LandmarkNarrative Review

Diagnostic Criteria for Fibromyalgia: Critical Review and Future Perspectives

Carmen M. Galvez-Sánchez & Gustavo A. Reyes del Paso·Journal of Clinical Medicine·2020

A critical review of the evolving ACR diagnostic criteria for fibromyalgia, concluding that despite the 2010 criteria and the 2011/2016 proposals, misdiagnosis and dissatisfaction among clinicians and patients persist.

Diagnosis & AssessmentRead →
●●●●● LandmarkCross-Sectional Study

Signs and Symptoms of Myofascial Pain: An International Survey of Pain Management Providers and Proposed Preliminary Set of Diagnostic Criteria

Rivers et al.·Pain Medicine·2015

International survey of 214 pain specialists achieved consensus that myofascial pain syndrome diagnosis relies primarily on tender spots that recreate symptoms when palpated. This led to the first proposed standardized diagnostic criteria for clinical and research use.

Diagnosis & AssessmentRead →
●●●●● LandmarkNarrative Review

Diagnosis of Myofascial Pain Syndrome

Gerwin, Robert D.·Physical Medicine and Rehabilitation Clinics of North America·2014

Comprehensive review of myofascial trigger point diagnosis emphasizing proper palpation techniques. Essential diagnostic criteria include taut band presence, point tenderness, and pain reproduction.

Diagnosis & AssessmentRead →
●●●●● LandmarkNarrative Review

Myofascial pain syndromes and their evaluation

Giamberardino et al.·Best Practice & Research Clinical Rheumatology·2011

Comprehensive review of myofascial pain syndromes showing they affect up to 85% of elderly individuals yet remain under-diagnosed. Evidence supports trigger point injection as gold standard treatment with systematic assessment of perpetuating factors.

Diagnosis & AssessmentRead →